Purchase Order 36C26126P0276
- Not listed
- Edwards Lifesciences LLC has been awarded a firm fixed-price purchase order valued at $32,500 for transcatheter aortic valve replacement (TAVR) surgical implants and prosthetics restocking. The contract, awarded December 30, 2025, with an ultimate completion date of March 29, 2026, will be performed in San Francisco, California, and funded by Veterans Integrated Service Network 21, a component of the U.S. Department of Veterans Affairs. This award carries no set-aside designation and...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation, has been awarded a firm fixed-price purchase order valued at $32,500 by the U.S. Department of Veterans Affairs through Veterans Integrated Service Network 21 for the restock of transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetics. The contract, which carries no set-aside designation, is scheduled for completion by March 14, 2026, with the place of performance located in San...
- Edwards Lifesciences LLC was awarded a $65,000 firm fixed-price purchase order by Veterans Integrated Service Network 21 (VISN 21) on October 28, 2025, for the procurement of transcatheter aortic valve replacement (TAVR) surgical implants and prosthetics. The contract is scheduled for completion by January 27, 2026, and will be performed in San Francisco, California. This award was made without a set-aside designation and represents Edwards Lifesciences LLC's continued role as a specialized...
- The U.S. Department of Veterans Affairs, through Veterans Integrated Service Network 21, awarded a $32.5K firm fixed-price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) surgical implants restocking. This contract, awarded December 29, 2025, with an ultimate completion date of March 28, 2026, supports the VA's mission to provide advanced cardiovascular care to veterans at the San Francisco facility. No set-aside designation was utilized for this...
- Edwards Lifesciences LLC was awarded a $32,500 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 21 on November 3, 2025, for transcatheter aortic valve replacement (TAVR) surgical implants and prosthetics. The contract, which carries no set-aside designation, is scheduled for completion by February 2, 2026, and will be performed in San Francisco, California. As the sole manufacturer of these specialized cardiovascular devices, Edwards Lifesciences LLC serves as the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, has been awarded a firm fixed-price purchase order valued at $34,000 by Veterans Integrated Service Network (VISN) 23 for transcatheter aortic valve replacement (TAVR) medical devices. The contract was awarded on November 10, 2025, with an ultimate completion date of November 12, 2025, and will be performed in Minneapolis, Minnesota. This award represents a direct...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leading provider of advanced cardiovascular medical devices, has been awarded a firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 for transcatheter aortic valve replacement (TAVR) equipment. The contract, awarded on September 19, 2025, carries a ceiling value of $34,000 and an ultimate completion date of September 22, 2025, with performance to be fulfilled in Minneapolis, Minnesota....
- Edwards Lifesciences LLC received a firm fixed-price purchase order valued at $32,500 from Veterans Integrated Service Network 21 for transcatheter aortic valve replacement (TAVR) surgical implants, with an ultimate completion date of February 11, 2026. The award was issued on November 12, 2025, with no set-aside designation and performance to be completed in San Francisco, California. As a subsidiary of Edwards Lifesciences Corporation, a global leader in structural heart disease medical...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leader in cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 on December 12, 2025, with an ultimate completion date of December 15, 2025. The contract, designated as a TAVR (Transcatheter Aortic Valve Replacement) procurement, will be performed in Minneapolis, Minnesota. This award represents no set-aside designation and reflects the...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $65,000 firm fixed-price purchase order to Edwards Lifesciences LLC on September 18, 2025, for the restock of transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetics. The contract, which is not set-aside designated, will be performed in San Francisco, California, with a completion date of December 17, 2025. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences...
Edwards Lifesciences LLC has been awarded a $32.5K firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 21 for the restock of transcatheter aortic valve replacement (TAVR) surgical implants. The contract, awarded on December 30, 2025, has an ultimate completion date of March 29, 2026, and will be performed in San Francisco, California. No set-aside designation was used for this procurement, and Edwards Lifesciences LLC serves as both the prime contractor and sole manufacturer of the required cardiac devices. This award reflects the company's established role as a critical supplier of specialized cardiovascular medical devices to the Department of Veterans Affairs. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, has consistently provided advanced heart valve technologies and surgical implants across multiple VISNs. The procurement supports the VA's healthcare mission by ensuring the availability of specialized implantable devices necessary for veteran cardiac care procedures, leveraging Edwards Lifesciences' expertise in transcatheter heart valve systems and related cardiovascular technologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.5k | 12/30/25 |